Free Consultation 215.567.2010

CR Attorneys Named 2016 Pennsylvania Super Lawyers

Posted on May 25, 2016 in News

We already know our attorneys are great, but it’s always nice to hear it from others! Super Lawyers 2016 named twelve Caesar Rivise attorneys to their competitive ranking of Pennsylvania pros. The annual list of top attorneys is carefully selected through peer nominations and evaluations, combined with third-party independent research.

Read More

The Court of Appeals for the Federal Circuit Finds Specific Jurisdiction in ANDA Patent Cases

Posted on Mar 21, 2016 in Blog

On March 18, 2016, the Court of Appeals for the Federal Circuit ruled for the first time that an ANDA filer can basically be sued anywhere unless it is unfair, widening broadly jurisdiction in ANDA cases. Mylan Inc. was sued twice in Delaware based on two ANDA filings and argued the Delaware court did not have specific or general jurisdiction over it.

Read More

Caesar Rivise Wins Motion to Transfer Case to the U.S. District Court for the Central District of California

Posted on Mar 4, 2016 in News

In the case of Access Business Group LLC v. BattleChem Distribution, Inc. and Divi’s Laboratories, LTD., 1:13-cv-00828-RJJ (US DC Western District of Michigan), the Honorable Robert J. Jonker on March 3, 2016 granted defendants’ Motion to Transfer a breach of contract and breach of warranty action to the Central District of California.

Read More

ANDA Litigation Basics Under the Hatch-Waxman Act and Medicare Prescription Drug, Improvement and Modernization Act of 2003

Posted on Nov 16, 2015 in Articles

Generic Drugs, Are safe, effective and less expensive than brand name prescriptions, Used in approximately 50-60% of all prescriptions dispensed, Have same active ingredient(s), route of administration, dosage form, strength, indications…

Read More

Caesar Rivise Obtains Federal Circuit Affirmance of a Denial of a Motion for Preliminary Injunction

Posted on Mar 13, 2015 in News

On March 12, 2015, the United States Court of Appeals for the Federal Circuit ruled in favor of Caesar Rivise clients Camber Pharmaceuticals, Inc. and InvaGen Pharmaceuticals, Inc. in a case filed by Roxane Laboratories, Inc. alleging infringement of its patent covering calcium acetate capsules and their use in the treatment of hyperphosphatemia in patients with chronic kidney disease.

Read More

U.S. Buyers and Their Legal Advisors Beware: Indian Court’s Injunction Against Glenmark’s Continued Infringement of Symed Lab’s Process Patent Suggests That Pharmaceutical Method Claims Are Becoming More Readily Enforceable in India

Posted on Jan 23, 2015 in Blog

An ad interim injunction passed by the Honorable Delhi High Court (on January 19, 2015) against Glenmark restrained infringement of Symed’s Process Patent Nos. IN 213062 and IN 213063.

Read More

Philadelphia

1635 Market Street, 12th Floor
Philadelphia, Pennsylvania 19103-2212

215-567-2010 | 215-751-1142

View Map

Lehigh Valley

6081 Hamilton Blvd Suite 600
Allentown, Pennsylvania 18106

610-255-7551 | 610-255-7542

View Map